Geode Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216M Buy
3,819,441
+145,352
+4% +$8.47M 0.01% 700
2025
Q4
$218M Buy
3,674,089
+131,969
+4% +$7.18M 0.01% 685
2025
Q3
$191M Buy
3,542,120
+67,682
+2% +$3.87M 0.01% 719
2025
Q2
$190M Buy
3,474,438
+43,185
+1% +$2.54M 0.01% 683
2025
Q1
$242M Buy
3,431,253
+142,475
+4% +$9.59M 0.02% 578
2024
Q4
$216M Buy
3,288,778
+28,728
+0.9% +$1.92M 0.02% 612
2024
Q3
$229M Buy
3,260,050
+60,692
+2% +$5.07M 0.02% 593
2024
Q2
$263M Buy
3,199,358
+212,643
+7% +$17.7M 0.02% 513
2024
Q1
$260M Buy
2,986,715
+114,283
+4% +$10.2M 0.02% 521
2023
Q4
$276M Buy
2,872,432
+109,996
+4% +$9.73M 0.03% 480
2023
Q3
$244M Buy
2,762,436
+51,411
+2% +$4.57M 0.03% 477
2023
Q2
$235M Buy
2,711,025
+48,902
+2% +$4.6M 0.03% 497
2023
Q1
$258M Buy
2,662,123
+78,019
+3% +$8.09M 0.03% 453
2022
Q4
$267M Buy
2,584,104
+69,581
+3% +$6.53M 0.04% 441
2022
Q3
$213M Buy
2,514,523
+42,707
+2% +$3.8M 0.03% 463
2022
Q2
$205M Buy
2,471,816
+17,579
+0.7% +$1.4M 0.03% 488
2022
Q1
$189M Buy
2,454,237
+54,894
+2% +$4.59M 0.02% 556
2021
Q4
$212M Buy
2,399,343
+76,459
+3% +$6.31M 0.03% 535
2021
Q3
$179M Buy
2,322,884
+13,962
+0.6% +$1.1M 0.02% 556
2021
Q2
$192M Buy
2,308,922
+140,877
+6% +$11.2M 0.03% 547
2021
Q1
$163M Buy
2,168,045
+110,904
+5% +$9.06M 0.03% 566
2020
Q4
$180M Buy
2,057,141
+69,325
+3% +$5.5M 0.03% 494
2020
Q3
$151M Sell
1,987,816
-96,620
-5% -$9.78M 0.03% 473
2020
Q2
$257M Buy
2,084,436
+2,143
+0.1% +$213K 0.06% 325
2020
Q1
$176M Buy
2,082,293
+146,481
+8% +$12.6M 0.05% 361
2019
Q4
$164M Buy
1,935,812
+107,612
+6% +$8.13M 0.03% 457
2019
Q3
$123M Buy
1,828,200
+21,321
+1% +$1.64M 0.03% 502
2019
Q2
$155M Buy
1,806,879
+52,797
+3% +$4.52M 0.04% 445
2019
Q1
$156M Buy
1,754,082
+110,575
+7% +$10.2M 0.04% 426
2018
Q4
$140M Buy
1,643,507
+92,519
+6% +$8.8M 0.04% 408
2018
Q3
$150M Buy
1,550,988
+22,596
+1% +$2.26M 0.04% 418
2018
Q2
$144M Buy
1,528,392
+56,446
+4% +$4.94M 0.04% 410
2018
Q1
$119M Buy
1,471,946
+25,767
+2% +$2.21M 0.04% 454
2017
Q4
$129M Buy
1,446,179
+19,011
+1% +$1.65M 0.04% 414
2017
Q3
$133M Buy
1,427,168
+24,328
+2% +$2.15M 0.05% 373
2017
Q2
$127M Buy
1,402,840
+79,799
+6% +$7.26M 0.05% 369
2017
Q1
$116M Buy
1,323,041
+73,845
+6% +$6.57M 0.05% 379
2016
Q4
$103M Buy
1,249,196
+110,575
+10% +$9.51M 0.05% 381
2016
Q3
$105M Buy
1,138,621
+82,192
+8% +$7.74M 0.05% 355
2016
Q2
$82.2M Buy
1,056,429
+45,519
+5% +$3.87M 0.04% 401
2016
Q1
$83.3K Buy
1,010,910
+47,547
+5% +$3.87M 0.04% 388
2015
Q4
$101M Buy
963,363
+19,214
+2% +$2.01M 0.06% 323
2015
Q3
$99.4M Buy
944,149
+12,916
+1% +$1.73M 0.06% 320
2015
Q2
$127M Buy
931,233
+54,043
+6% +$6.7M 0.07% 278
2015
Q1
$109M Buy
877,190
+96,036
+12% +$10.2M 0.06% 315
2014
Q4
$70.6M Buy
781,154
+24,679
+3% +$2.05M 0.04% 411
2014
Q3
$54.6M Buy
756,475
+13,555
+2% +$891K 0.04% 453
2014
Q2
$46.2M Buy
742,920
+21,678
+3% +$1.31M 0.03% 502
2014
Q1
$49.2M Buy
721,242
+43,211
+6% +$3.18M 0.03% 469
2013
Q4
$47.6M Buy
678,031
+78,584
+13% +$5.34M 0.03% 464
2013
Q3
$43.3M Buy
599,447
+33,765
+6% +$2.24M 0.03% 450
2013
Q2
$31.6M Buy
+565,682
New +$35.3M 0.03% 500

Other funds holding BMRN